COMPANY

Orionis Biosciences

HQ: Waltham, MA (US office) source · orionisbio.com ↗

Location: Waltham, MA (US office) · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Advanced Solid Tumors Cancer ORB-021 ORB-011

Timeline

May 21, 2025 Partnership Partnership / licensing announced May 21, 2025. Source: company's own press page. source ↗
Nov 21, 2024 Trial start Phase 1: ORB-021 In Patients With Advanced Solid Tumors source ↗
Aug 21, 2023 Trial start Phase 1: ORB-011 In Patients With Advanced Solid Tumors source ↗

Jan 29, 2027 (ESTIMATED) · Phase 1 · ORB-021 In Patients With Advanced Solid Tumors · NCT06607939

Estimated primary completion per ClinicalTrials.gov. Dates move.

Last 2 years.

May 21, 2025 Partnership / licensing announced May 21, 2025. Source: company's own press page. source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT06607939	ORB-021 In Patients With Advanced Solid Tumors	Phase 1	Recruiting	Nov 21, 2024	Jan 29, 2027 (estimated)
NCT05947474	ORB-011 In Patients With Advanced Solid Tumors	Phase 1	Completed	Aug 21, 2023	May 29, 2026 (actual)